Abbvie, Lda secures contract for Acquisition Of Glecaprevir 100 Mg Pibrentasvir 40 Mg Comp (8 And 16 Week Treatment), Sofosbuvir 400 Mg Velpatasvir 100 Mg Voxilaprevir 100 Mg Comp (12 Week Treatment) And Sofosbuvir 400

Portugal, Nov. 24 -- Portugal based Abbvie, Lda has secured contract from Unidade Local De Saude De Sao Jose, E. P. E. for Acquisition Of Glecaprevir 100 Mg Pibrentasvir 40 Mg Comp (8 And 16 Week Treatment), Sofosbuvir 400 Mg Velpatasvir 100 Mg Voxilaprevir 100 Mg Comp (12 Week Treatment) And Sofosbuvir 400. The value of the contract is worth 50050007 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....